APA (7th ed.) Citation

M, S., M, F., PP, S., KV, G., O, G., RA, W., . . . M, G. (2026). Calprotectin and serum amyloid A for disease activity assessment in giant cell arteritis and polymyalgia rheumatica: Results from a prospective single-centre cohort study. Rheumatology international, 46(3), . https://doi.org/10.1007/s00296-026-06081-9

Chicago Style (17th ed.) Citation

M, Schmalzing, et al. "Calprotectin and Serum Amyloid A for Disease Activity Assessment in Giant Cell Arteritis and Polymyalgia Rheumatica: Results from a Prospective Single-centre Cohort Study." Rheumatology International 46, no. 3 (2026). https://doi.org/10.1007/s00296-026-06081-9.

MLA (9th ed.) Citation

M, Schmalzing, et al. "Calprotectin and Serum Amyloid A for Disease Activity Assessment in Giant Cell Arteritis and Polymyalgia Rheumatica: Results from a Prospective Single-centre Cohort Study." Rheumatology International, vol. 46, no. 3, 2026, https://doi.org/10.1007/s00296-026-06081-9.